Norris Medicines Limited (BOM:524414)
India · Delayed Price · Currency is INR 12.87
-1.42 (-9.94%)
At close: Jan 21, 2026
Norris Medicines Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.65 | 0.4 | 0.38 | 0.2 | 0.19 | 0.21 | Upgrade |
Cash & Short-Term Investments | 0.65 | 0.4 | 0.38 | 0.2 | 0.19 | 0.21 | Upgrade |
Cash Growth | 234.72% | 5.87% | 84.82% | 9.12% | -10.08% | -67.38% | Upgrade |
Accounts Receivable | 6.35 | 14.09 | 10.61 | 11 | 10.92 | 17.88 | Upgrade |
Receivables | 6.35 | 21.71 | 17.72 | 11 | 10.92 | 17.88 | Upgrade |
Inventory | 48.23 | 41.28 | 43.34 | 32.05 | 24.26 | 53.17 | Upgrade |
Prepaid Expenses | - | - | - | - | 0.38 | 0.23 | Upgrade |
Other Current Assets | 7.34 | - | - | 5.95 | 6.98 | 10.84 | Upgrade |
Total Current Assets | 62.57 | 63.39 | 61.43 | 49.2 | 42.73 | 82.33 | Upgrade |
Property, Plant & Equipment | 50.32 | 52.68 | 57.86 | 64.69 | 70.69 | 76.71 | Upgrade |
Long-Term Investments | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | Upgrade |
Long-Term Deferred Tax Assets | 9.04 | 9.04 | 9.63 | 10.52 | 16.09 | 26.87 | Upgrade |
Other Long-Term Assets | 12.58 | -0 | 0 | 12.32 | 12.27 | 11.8 | Upgrade |
Total Assets | 134.91 | 138.1 | 141.87 | 136.86 | 141.91 | 197.87 | Upgrade |
Accounts Payable | 30.74 | 25.7 | 17.76 | 13.8 | 13.25 | 52.41 | Upgrade |
Accrued Expenses | - | 31.64 | 30.57 | 29.83 | 22.51 | 10.16 | Upgrade |
Short-Term Debt | 30.34 | 30.53 | 29.32 | 29.79 | 29.76 | 28.62 | Upgrade |
Other Current Liabilities | 48.42 | 13.63 | 14.6 | 3.62 | 2.31 | 25.74 | Upgrade |
Total Current Liabilities | 109.5 | 101.5 | 92.26 | 77.05 | 67.84 | 116.94 | Upgrade |
Long-Term Debt | 184.38 | 185.27 | 185.92 | 184.25 | 181.01 | 155.23 | Upgrade |
Other Long-Term Liabilities | - | 0 | 0 | - | 0 | 0 | Upgrade |
Total Liabilities | 293.88 | 286.77 | 278.17 | 261.3 | 248.85 | 272.17 | Upgrade |
Common Stock | 99.26 | 99.26 | 99.26 | 99.26 | 99.26 | 99.26 | Upgrade |
Retained Earnings | -258.22 | -247.93 | -235.56 | -223.69 | -206.2 | -173.56 | Upgrade |
Comprehensive Income & Other | - | 0 | 0 | - | - | - | Upgrade |
Shareholders' Equity | -158.96 | -148.68 | -136.3 | -124.43 | -106.94 | -74.3 | Upgrade |
Total Liabilities & Equity | 134.91 | 138.1 | 141.87 | 136.86 | 141.91 | 197.87 | Upgrade |
Total Debt | 214.72 | 215.8 | 215.24 | 214.04 | 210.77 | 183.85 | Upgrade |
Net Cash (Debt) | -214.07 | -215.41 | -214.86 | -213.84 | -210.58 | -183.65 | Upgrade |
Net Cash Per Share | -21.48 | -21.54 | -21.48 | -21.38 | -21.06 | -18.36 | Upgrade |
Filing Date Shares Outstanding | 9.98 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Total Common Shares Outstanding | 9.98 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Working Capital | -46.93 | -38.11 | -30.83 | -27.84 | -25.11 | -34.61 | Upgrade |
Book Value Per Share | -15.94 | -14.87 | -13.63 | -12.44 | -10.69 | -7.43 | Upgrade |
Tangible Book Value | -158.96 | -148.68 | -136.3 | -124.43 | -106.94 | -74.3 | Upgrade |
Tangible Book Value Per Share | -15.94 | -14.87 | -13.63 | -12.44 | -10.69 | -7.43 | Upgrade |
Land | - | 5.84 | 5.84 | 5.84 | 5.84 | 5.84 | Upgrade |
Buildings | - | 58.5 | 58.5 | 58.5 | 58.5 | 58.5 | Upgrade |
Machinery | - | 213.27 | 213.08 | 215.2 | 214.9 | 214.35 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.